The Joint (JYNT) stock price, revenue, and financials

The Joint market cap is $210.7 m, and annual revenue was $48.45 m in FY 2019

$210.7 M

JYNT Mkt cap, 29-May-2020

$13.6 M

The Joint Revenue Q1, 2020
The Joint Gross profit (Q1, 2020)12.2 M
The Joint Gross profit margin (Q1, 2020), %89.1%
The Joint Net income (Q1, 2020)814.9 K
The Joint EBIT (Q1, 2020)753.4 K
The Joint Cash, 31-Mar-202010.7 M
The Joint EV216.5 M

The Joint Revenue Breakdown

Embed Graph

The Joint revenue breakdown by business segment: 41.7% from Corporate Clinics and 58.3% from Franchise Operations

The Joint Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2019

Revenue

7.1m13.8m20.5m25.2m48.5m

Revenue growth, %

94%48%23%

Cost of goods sold

2.2m2.8m2.9m3.3m5.6m

Gross profit

4.9m11.0m17.6m21.9m42.9m

Gross profit Margin, %

68%80%86%87%89%

Sales and marketing expense

1.2m6.9m

General and administrative expense

5.1m15.4m22.1m18.1m39.4m

Operating expense total

6.3m18.2m26.5m18.1m46.3m

Depreciation and amortization

210.1k1.3m2.6m2.0m1.9m

EBIT

(9.3m)(15.0m)(3.2m)

EBIT margin, %

(67%)(73%)(13%)

Pre tax profit

(15.0m)(3.2m)3.4m

Income tax expense

235.9k164.4k(35.9k)48.7k

Net Income

(3.0m)(8.8m)(15.2m)3.3m

Quarterly

USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2019Q3, 2019Q1, 2020

Revenue

1.8m2.5m3.4m4.1m4.3m5.0m5.5m5.7m6.0m6.5m11.2m12.7m13.6m

Cost of goods sold

585.8k545.3k791.8k745.5k740.0k727.7k718.8k742.1k770.2k819.2k1.3m1.4m1.5m

Gross profit

1.2m2.0m2.6m3.4m3.5m4.2m4.8m4.9m5.2m5.7m9.9m11.3m12.2m

Gross profit Margin, %

68%78%77%82%83%85%87%87%87%87%88%89%89%

Sales and marketing expense

1.8m1.8m2.1m

General and administrative expense

1.2m2.8m3.4m4.3m5.7m5.6m5.4m4.6m4.7m4.5m9.4m10.6m11.4m

Operating expense total

1.2m2.8m3.4m4.3m5.7m5.6m5.4m4.6m4.7m4.5m9.4m10.7m11.4m

Depreciation and amortization

278.5k421.4k575.5k637.1k695.6k578.0k503.2k468.8k404.5k538.4k654.2k

EBIT

(310.8k)(1.9m)(1.8m)(2.1m)(3.5m)(3.2m)(2.6m)(1.6m)(984.5k)(377.6k)487.6k640.4k753.4k

EBIT margin, %

(17%)(76%)(54%)(50%)(82%)(64%)(48%)(28%)(16%)(6%)4%5%6%

Interest expense

15.1k16.7k

Pre tax profit

(1.9m)(3.5m)(3.2m)(2.6m)(1.6m)(1.0m)(367.7k)472.5k623.7k749.0k

Income tax expense

163.1k(6.1k)(44.4k)(73.5k)(14.3k)(40.6k)(2.6k)(36.1k)10.2k6.7k65.9k

Net Income

(202.4k)(1.9m)462.3k617.0k814.9k

The Joint Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

20.8m16.8m3.0m4.2m8.7m8.5m

Accounts Receivable

704.9k743.2k1.0m1.1m1.2m2.6m

Prepaid Expenses

542.3k882.0k1.1m

Inventories

375.9k366.0k499.5k

Current Assets

23.4m19.0m5.7m6.7m11.7m13.3m

PP&E

1.1m7.1m4.7m3.8m3.7m

Goodwill

677.2k2.5m2.8m2.9m2.9m4.2m

Total Assets

28.6m33.4m17.1m16.9m23.5m43.7m

Accounts Payable

1.3m2.0m1.1m1.1m1.3m1.5m

Short-term debt

100.0k1.2m2.3m

Current Liabilities

4.3m7.5m5.9m5.0m8.7m13.6m

Long-term debt

1.1m11.9m

Total Debt

1.2m1.2m14.2m

Total Liabilities

10.1m12.0m21.2m38.0m

Common Stock

13.6k13.8k13.9k

Preferred Stock

Additional Paid-in Capital

21.4m35.3m36.4m37.2m38.2m39.5m

Retained Earnings

(5.0m)(13.8m)(29.0m)(32.3m)(35.8m)(33.6m)

Total Equity

15.6m20.7m6.9m4.9m2.4m5.7m

Debt to Equity Ratio

0.2 x0.5 x

Debt to Assets Ratio

0.1 x0.1 x

Financial Leverage

1.8 x1.6 x2.5 x3.5 x10 x7.6 x

Quarterly

USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

2.4m17.1m12.6m9.5m10.4m6.1m3.4m2.7m3.0m2.6m4.0m4.6m5.6m8.1m9.5m7.8m10.7m

Accounts Receivable

333.2k775.7k458.9k605.9k1.6m1.8m1.9m1.2m1.1m1.3m1.0m1.2m1.2m1.1m1.0m1.3m1.8m

Prepaid Expenses

69.0k80.3k97.2k151.8k445.0k359.7k891.9k893.5k557.2k604.8k733.5k702.2k830.6k887.7k1.1m1.1m

Current Assets

5.5m19.5m14.5m11.6m13.6m9.5m7.4m5.8m5.6m5.4m6.6m7.2m8.4m10.9m12.4m11.3m14.8m

PP&E

794.4k1.6m2.7m3.6m8.0m8.2m7.5m4.4m4.1m3.8m3.7m3.7m3.3m4.2m5.0m5.7m8.1m

Goodwill

1.8m2.7m2.9m2.5m2.9m2.8m2.8m2.8m2.8m2.9m2.9m2.9m3.2m3.2m4.1m4.2m

Total Assets

9.8m26.5m24.0m22.5m28.7m25.3m22.1m16.5m16.1m15.6m18.2m18.8m19.8m33.9m36.5m41.8m46.4m

Accounts Payable

677.3k1.6m1.5m1.4m1.6m1.1m820.7k1.1m971.3k718.4k935.7k723.4k911.6k1.2m1.2m1.7m1.9m

Short-term debt

115.0k479.4k466.9k591.4k550.4k331.5k168.0k100.0k100.0k100.0k100.0k1.0m1.0m1.0m2.5m

Current Liabilities

4.0m4.8m5.3m5.9m6.2m5.4m5.3m5.0m4.6m4.1m5.7m5.6m6.2m10.9m11.9m13.4m12.9m

Long-term debt

140.0k140.0k167.5k461.4k550.4k331.5k1.2m1.1m1.1m1.1m1.1m9.1m9.1m11.8m14.0m

Total Debt

255.0k619.4k634.4k1.1m1.1m663.0k1.3m1.2m1.2m1.2m1.2m10.1m10.1m12.8m16.5m

Total Liabilities

11.4m12.7m11.9m11.6m11.3m10.5m9.9m11.0m11.5m11.0m17.2m17.4m18.5m31.9m33.7m38.0m39.5m

Common Stock

5.4k10.3k10.3k10.4k13.1k13.3k13.3k13.4k13.5k13.5k13.6k13.7k13.8k13.8k13.9k14.0k

Preferred Stock

25.0

Additional Paid-in Capital

1.6m21.6m21.7m22.1m35.5m36.1m36.3m36.6m36.7m36.8m37.5m37.9m38.0m38.6m38.8m39.3m39.8m

Retained Earnings

(2.4m)(6.9m)(8.8m)(10.4m)(17.3m)(20.6m)(23.2m)(30.6m)(31.6m)(32.0m)(36.3m)(36.4m)(36.6m)(36.4m)(36.0m)(35.4m)(32.8m)

Total Equity

(1.6m)13.9m12.2m10.9m17.4m14.7m12.3m5.5m4.6m4.7m1.1m1.3m1.3m2.1m2.7m3.8m6.9m

Debt to Equity Ratio

0 x0.1 x0.1 x0.1 x0.1 x0.1 x0.2 x0.3 x0.3 x1.1 x0.9 x4.9 x3.7 x

Debt to Assets Ratio

0 x0 x0 x0 x0 x0 x0.1 x0.1 x0.1 x0.1 x0.1 x0.3 x0.3 x

Financial Leverage

-6 x1.9 x2 x2.1 x1.7 x1.7 x1.8 x3 x3.5 x3.3 x17.2 x14 x14.8 x16.4 x13.3 x11 x6.7 x

The Joint Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(3.0m)(8.8m)(15.2m)(3.3m)253.1k3.3m

Depreciation and Amortization

210.1k1.3m2.6m2.0m1.6m1.9m

Accounts Receivable

(369.5k)(100.0k)(999.5k)(124.1k)(75.3k)(1.8m)

Inventories

(352.2k)9.9k(133.5k)

Accounts Payable

1.0m(291.5k)(953.1k)(36.8k)63.6k75.9k

Cash From Operating Activities

(437.4k)(6.8m)(10.8m)156.4k5.5m7.5m

Purchases of PP&E

(659.3k)(4.1m)(1.6m)(449.2k)(1.1m)(3.5m)

Cash From Investing Activities

(2.1m)(10.0m)(2.7m)(372.9k)(1.2m)(7.1m)

Short-term Borrowings

(231.5k)(1.1m)

Long-term Borrowings

(22.0k)

Cash From Financing Activities

19.8m12.8m(239.9k)1.4m326.3k(597.0k)

Net Change in Cash

1.2m4.5m(213.1k)

Income Taxes Paid

420.3k

Quarterly

USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

(464.0k)(1.9m)(3.8m)(5.4m)(3.5m)(6.8m)(9.4m)(1.6m)(2.7m)(3.1m)(386.9k)(429.7k)(581.5k)952.6k1.4m2.0m814.9k

Depreciation and Amortization

141.7k122.6k401.1k822.5k575.5k1.2m1.9m578.0k1.1m1.6m387.4k792.4k1.2m365.7k770.1k1.3m654.2k

Accounts Receivable

(8.6k)(71.6k)241.6k94.7k(902.2k)(1.1m)(1.1m)(214.9k)(161.3k)(303.6k)90.8k104.9k(59.9k)(241.8k)(227.1k)(533.1k)809.6k

Accounts Payable

450.5k304.2k180.7k164.9k(1.2m)(1.1m)(1.2m)34.2k(83.6k)(336.5k)(133.0k)(384.5k)(225.8k)(276.1k)(154.5k)223.2k(80.7k)

Cash From Operating Activities

(114.4k)(1.3m)(2.5m)(4.0m)(5.8m)(8.1m)(10.3m)(1.3m)(734.7k)(1.4m)(33.1k)613.2k1.9m459.5k2.8m4.7m1.5m

Purchases of PP&E

(538.3k)(14.0k)(485.3k)(1.5m)(287.9k)(1.3m)(1.5m)(39.3k)(106.3k)(190.6k)(183.7k)(370.8k)(531.2k)(526.0k)(1.6m)(2.3m)(1.3m)

Cash From Investing Activities

(516.5k)(2.4m)(5.6m)(7.2m)(545.7k)(2.5m)(2.6m)(29.3k)(80.4k)(150.7k)(142.3k)(366.9k)(698.8k)(1.2m)(2.2m)(6.0m)(1.2m)

Short-term Borrowings

(25.0k)(110.0k)(120.5k)(217.4k)(436.3k)(163.5k)(231.5k)(231.5k)(100.0k)(100.0k)(100.0k)

Long-term Borrowings

(5.3k)(10.7k)(16.3k)(7.2k)

Cash From Financing Activities

(511.9k)(25.0k)(110.0k)(119.9k)(152.9k)(454.3k)952.8k852.0k1.2m23.3k141.6k286.7k84.6k128.9k391.3k2.1m

Net Change in Cash

(1.1m)(3.7m)(8.2m)(11.3m)(6.4m)(10.7m)(13.4m)(333.3k)36.9k(381.2k)(152.1k)1.5m(657.5k)759.5k(859.0k)2.3m

Interest Paid

135.01.4k

Income Taxes Paid

420.3k

The Joint Ratios

USDY, 2020

EV/EBIT

287.3 x

EV/CFO

147.1 x

Financial Leverage

6.7 x

The Joint Operating Metrics

FY, 2014FY, 2015FY, 2016

Clinics

246 312 370

Patient Visits

2.17 m3.20 m4.10 m

The Joint Employee Rating

3.6252 votes
Culture & Values
3.6
Work/Life Balance
3.3
Senior Management
3.4
Salary & Benefits
3.1
Career Opportunities
3.2
Source